| Application no. and date | 18758120.2 (espacenet) (Federated) (European Patent Register), 20180221 | | Patent/reg. no. and date | DK/EP 3585442, 20231011 | | Publication date | 20200101 | | Priority no. and date | US 201762463316 P, 20170224, US 201715820708, 20171122 | | EP pub. no. and date |
EP 3585442 20200101 | | Effective date | | | Applicant/owner | Immunomedics, Inc., c/o Gilead Sciences, Inc.
333 Lakeside Drive
Foster City
CA 94404, US | | Applicant ref. no. | | | Inventor | GOLDENBERG, David M., 300 American Road
Morris Plains, New Jersey 07950, US,
GOVINDAN, Serengulam V., 300 American Road
Morris Plains, New Jersey 07950, US | | Representative | | | Opponent | | | IPC Class | A61K 31/137 (2006.01) , A61K 31/138 (2006.01) , A61K 31/198 (2006.01) , A61K 31/255 (2006.01) , A61K 31/33 (2006.01) , A61K 31/407 (2006.01) , A61K 31/4184 (2006.01) , A61K 31/4535 (2006.01) , A61K 31/513 (2006.01) , A61K 31/517 (2006.01) , A61K 31/555 (2006.01) , A61K 31/7068 (2006.01) , A61K 47/68 (2017.01) , C07K 16/30 (2006.01) | | Title | THERAPY OF SMALL-CELL LUNG CANCER (SCLC) WITH A TOPOISOMERASE-I INHIBITING ANTIBODY-DRUG CONJUGATE (ADC) TARGETING TROP-2 | | Int. application no. | US2018019025 | | Int. publication no. | WO2018156634 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
